Federico Quaini

9PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersMolecular targetsGene and molecular therapyImmunogenetics (incl. genetic immunology)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 10, 2026
PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progression.

|May 19, 2026
Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic Leukemia.

|Mar 23, 2026
Transcriptomic analysis reveals lipid metabolism and macrophage involvement associated with nintedanib treatment in a rat bleomycin model.

Martina Bonatti, Vanessa Pitozzi, Paola Caruso

|Jan 10, 2026
In Vivo Target Engagement Assessment of Nintedanib in a Double-Hit Bleomycin Lung Fibrosis Rat Model.

Vanessa Pitozzi, Paola Lorenza Caruso, Silvia Pontis

|Dec 13, 2024
Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC.

Giulia Mazzaschi, Cristina Marrocchio, Lucas Moron Dalla Tor

|Sep 28, 2024
CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase.

Bruno Lorusso, Antonella Nogara, Rodanthi Fioretzaki

Pageof 2

Frequent Collaborators

6 joint publications

Bruno Lorusso

4 joint publications

Costanza Anna Maria Lagrasta

3 joint publications

Mariateresa Giaimo

3 joint publications

Gregorio Monica